Skip to content
  • Saturday, 12 September 2026
  • 6:39 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Paris is emerging as a focal point for Europe’s next phase in oncology, as science, capital, and industry converge at Campus Grand Parc.
Pharmaceutical R&D

Paris is emerging as a focal point for Europe’s next phase in oncology, as science, capital, and industry converge at Campus Grand Parc.

Teuku Ryan Jul 4, 2026 0

The recent inauguration of THE HIVE at Campus Grand Parc in Paris marks a significant inflection point for Europe’s oncology…

Read More
Data Science & Bioinformatics

The 7 Best Ways to Fund Your Startup Idea: A Comprehensive Guide to Navigating the Capital Landscape

Evan Lee Salim Jun 15, 2026 0

The journey of transforming an innovative idea into a thriving enterprise often hinges on securing adequate capital. While venture capital…

Read More
Pharmaceutical R&D

CVC Capital Partners and Groupe Bruxelles Lambert Launch $12.4 Billion Takeover Bid for Recordati, Signaling Potential Shift to Private Ownership

Teuku Ryan May 23, 2026 0

One of Italy’s few remaining publicly traded large pharmaceutical companies, Recordati, is on the cusp of transitioning to private ownership…

Read More
Pharmaceutical R&D

Global Healthcare Giants Unite: GHO Capital and CBC Group Forge Largest Dedicated Investment Manager with $21 Billion AUM

Teuku Ryan May 20, 2026 0

Two prominent forces in specialized healthcare investment, Global Healthcare Opportunities (GHO) and CBC Group, have announced a groundbreaking merger to…

Read More
Pharmaceutical R&D

AI Tools Revolutionize Pharmaceutical Administration, Freeing Up Valuable Human Capital

Teuku Ryan Apr 27, 2026 0

The pharmaceutical industry is experiencing a significant transformation as artificial intelligence (AI) tools move beyond experimental phases to deliver tangible…

Read More
Pharmaceutical R&D

Jeito Capital’s Second Fund Closes Above Target, Bolstering European Biopharma Investment to Over €1.6 Billion

Teuku Ryan Apr 10, 2026 0

Global independent private equity fund Jeito Capital has achieved a significant milestone in European biopharma investment with the successful closure…

Read More
Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit IDTWiV 1284: Clinical Update with Dr. Daniel GriffinHKU Researchers Identify Molecular Exercise Sensor Piezo1 as Key to Preventing Osteoporosis and Bone LossHow the Human Brain Separates Content and Context to Form Memories: A Study from the University of Bonn
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
The oral exposure challenge in PROTACs: What drug developers need to solve earlyAttention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological LandscapeHarmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum InformationSolstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
The oral exposure challenge in PROTACs: What drug developers need to solve early
Lana Keisha Sep 12, 2026
Neuroscience & Brain Research
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
Rifan Muazin Sep 12, 2026
Advanced Materials Science
Harmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum Information
Nila Kartika Wati Sep 12, 2026
Pharmaceutical R&D
Solstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
Teuku Ryan Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ